High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date changed from estimate of Mar 2027 to Jul 2, 2026
    • Study completion date: Mar 2027 to Jan 2027
    • Eligibility criteria expanded, about 21 words
  2. Trial status changed: Recruiting → Active, Not Recruiting
    • Enrollment reduced: 54 → 39 participants
    • Site details revised
    v9
  3. 5 versions Re-verified since Jan 31, 2025, no change to tracked fieldsv4-v8
  4. Enrollment target: 30 to 54
    • Primary endpoints: 6 to 7
    • Eligibility criteria expanded, about 55 words
    • Site contact updated
    v3
  5. Start date: Feb 19, 2024 to Apr 4, 2024v2
  6. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to evaluate the feasibility and acceptability of a dietary intervention (FEED-FF) that includes fermented foods (FF), among locally advanced rectal cancer patients and non-small cell lung cancer (NSCLC) patients, and to explore whether this diet can improve outcomes in rectal cancer patients receiving chemoradiation and NSCLC patients receiving immunotherapy.
Trial Details
NCT Number NCT06337552
Lead Sponsor H. Lee Moffitt Cancer Center and Research Institute
Conditions
(from sponsor)		 Rectal Cancer, Non-Small Cell Lung Cancer
Related terms Carcinoma, Non-Small-Cell Lung, Rectal Neoplasms
Enrollment 39 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov